TRIM21 and nasopharyngeal carcinoma: TRIM21 promoted degradation of mitochondrial voltage-dependent anion-selective channel protein 2 (VDAC2) through K48-linked ubiquitination in nasopharyngeal carcinoma, thereby inhibiting type I interferon response after radiotherapy in nasopharyngeal carcinoma [37].